BlinatumomabDevelopment of drug resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1847卷 / 1期

关键词：

D O I：

10.1007/s40278-021-92658-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：101 / 101

相关论文

共 50 条

[31] TemozolomideHypermutagenesis and drug resistance: case report
Reactions Weekly, 2021, 1851 (1) : 341 - 341
[32] InfliximabDevelopment of drug resistance: case report
Reactions Weekly, 2021, 1847 (1) : 244 - 244
[33] BedaquilineEmergence of drug resistance: case report
Reactions Weekly, 2019, 1777 (1) : 52 - 52
[34] CrizotinibDevelopment of drug resistance: case report
Reactions Weekly, 2021, 1882 (1) : 158 - 158
[35] CrizotinibDevelopment of drug resistance: case report
Reactions Weekly, 2018, 1705 (1) : 104 - 104
[36] EmicizumabDevelopment of drug resistance: case report
Reactions Weekly, 2022, 1888 (1) : 165 - 165
[37] ImatinibThrombocytopenia and drug resistance: case report
Reactions Weekly, 2010, 1310 (1) : 28 - 28
[38] MeropenemDevelopment of drug resistance: case report
Reactions Weekly, 2020, 1785 (1) : 329 - 329
[39] TrastuzumabDevelopment of drug resistance: case report
Reactions Weekly, 2016, 1632 (1) : 300 - 300
[40] ImatinibDevelopment of drug resistance: case report
Reactions Weekly, 2020, 1809 (1) : 128 - 128

← 1 2 3 4 5 →